EGFR and glioblastoma: Several compounds successfully inhibit EGFR signaling, for example, Higenamine89, 20(R, S)-protopanaxatriol, a metabolite from protopanaxatriol ginsenosides90, and Tubeimoside-I, which increases the sensitivity of glioblastoma cells towards temozolomide91.